RIPK4 and nasopharyngeal carcinoma: Studies have shown that RIPK4 is upregulated in nasopharyngeal carcinoma tissues and facilitates the progression of tumours by promoting the expression of VEGF in nasopharyngeal carcinoma cells (Yongqian et al., 2018).